CAPPS VICKIE L 4

What Happened
Vickie L. Capps, a director of Orthofix Medical Inc. (OFIX), received an award of 14,965 deferred stock units (DSUs) on June 10, 2026. The units were granted at $0.00 per share (no cash exchanged). These DSUs are a contingent right to receive one share of common stock per unit once they vest.

Key Details

• Transaction type: Award/Grant (code A) of 14,965 deferred stock units on 2026-06-10. Price per unit: $0.00. Report filed 2026-06-12.
• Vesting: DSUs vest in full on the first anniversary of the grant date (subject to continued service). Per footnote, each DSU represents a contingent right to one common share; vested DSUs convert into common stock within 45 days of the reporting person’s termination of service.
• Shares/units beneficially owned after this grant: 37,649 total (includes 21,934 previously reported DSUs and 750 shares acquired under Orthofix’s Stock Purchase Plan on 4/30/2026, plus the 14,965 DSUs just granted).
• Footnotes: F1 describes vesting and settlement terms for the DSUs. F2 notes prior DSUs and the 4/30/2026 Stock Purchase Plan shares (SPP acquisitions are exempt from Section 16(b)).
• Timeliness: Filing covers a 6/10/2026 grant and was filed on 6/12/2026 — appears timely (within typical Section 16 reporting windows).

Context
Deferred stock units are a form of equity compensation that do not result in immediate share issuance or cash proceeds; they align director compensation with long-term equity performance and require continued service to vest. This is an award, not an open-market purchase or sale, and therefore is a routine compensation-related transaction rather than an explicit buy or sell signal.